$0.1534
-0.0117-7.09%
Últ. Act.: Oct 26, 7:26 PM
aTyr Pharma (ATYR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.15 | $-0.18 | $-0.19 |
| Actual | $-0.11 | $-0.11 | $-0.14 | $-0.26 |
| Surprise | +8.33% | +26.7% | +22.2% | -36.8% |
| Revenue | ||||
| Estimate | — | $20000 | $20000 | $4.8M |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | -100.0% | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.10 | $-0.10 | $-0.16 | $-0.15 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.11 | $-0.12 | 8.33 % |
| Q1 | May 15, 2026 | $-0.11 | $-0.15 | 26.7 % |
| Q4 | Mar 5, 2026 | $-0.14 | $-0.18 | 22.2 % |
| Q3 | Nov 6, 2025 | $-0.26 | $-0.19 | -36.8 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 15, 2026 | $0 | $20.00K | -100.0 % |
| Q4 | Mar 5, 2026 | $0 | $20.00K | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $4.80M | -100.0 % |
| Q3 | Nov 7, 2024 | $0 | $20.00K | -100.0 % |